Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.50 |
| ▸ | CDC25B | P30305 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7034495 | 1.00 | MEN1 (0.56) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL13057738 | 1.00 | MEN1 (0.56) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL14047324 | 1.00 | MEN1 (0.56) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL12999684 | 1.00 | MEN1 (0.56) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL14047326 | 1.00 | MEN1 (0.56) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL15011454 | 0.93 | ALOX15 (0.50) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL21627 | 0.91 | MEN1 (0.44) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL13280283 | 0.91 | MEN1 (0.44) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL29473918 | 0.91 | MEN1 (0.44) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL9793534 | 0.91 | MEN1 (0.44) | MEN1CYP3A4ALOX15KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215354-A1 | FLUX CLEANING COMPOSITION | NAN YA PLASTICS CORPORATION (TW) | 2025-07-03 | — | — | US | claimed |
| CN-110127869-B | Environment-friendly neutral scale and corrosion inhibitor for oil extraction and preparation method thereof | 黑龙江益瑞化工有限公司 | 2020-10-09 | — | — | CN | claimed |
| US-4179293-A | HYDROQUINONE COMPOUND AS AN ANTIFOGGING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1979-12-18 | — | — | US | claimed |
| US-20250215354-A1 | FLUX CLEANING COMPOSITION | NAN YA PLASTICS CORPORATION (TW) | 2025-07-03 | — | — | US | disclosed |
| CN-110127869-B | Environment-friendly neutral scale and corrosion inhibitor for oil extraction and preparation method thereof | 黑龙江益瑞化工有限公司 | 2020-10-09 | — | — | CN | disclosed |
| EP-2084249-B1 | FUEL COMPOSITIONS COMPRISING FARNESANE AND FARNESANE DERIVATIVES AND METHOD OF MAKING AND USING SAME | AMYRIS INC (US) | 2016-12-21 | — | — | EP | disclosed |
| EP-2809642-A1 | ALKOXYLATES OF HYDROGENATED FARNESOLS AND USE THEREOF | BASF SE (DE) | 2014-12-10 | — | — | EP | disclosed |
| WO-2013113824-A1 | ALKOXYLATES OF HYDROGENATED FARNESOLS AND USE THEREOF | BASF SE (DE) | 2013-08-08 | — | — | WO | disclosed |
| US-20130197276-A1 | ALKOXYLATES OF HYDROGENATED FARNESOLS AND USE THEREOF | BALDENIUS, KAI-UWE (DE) | 2013-08-01 | — | — | US | disclosed |
| US-7846222-B2 | Fuel compositions comprising farnesane and farnesane derivatives and method of making and using same | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2010-12-07 | — | — | US | disclosed |
| US-7846222-B2 | Fuel compositions comprising farnesane and farnesane derivatives and method of making and using same | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2010-12-07 | — | — | US | disclosed |
| US-20070238629-A1 | Fragrance compositions from tertiary terpene alcohols | RENESSENZ LLC | 2007-10-11 | — | — | US | disclosed |
| EP-1122236-B1 | Process for producing 6-methyl-3-hepten-2-one, and process for producing phyton or isophytol | KURARAY CO (JP) | 2004-09-29 | — | — | EP | disclosed |
| EP-0816321-B1 | Process for producing 6-methyl-2-heptanone analogues, and process for producing phyton and isophytol | KURARAY CO (JP) | 2002-06-05 | — | — | EP | disclosed |
| EP-1122236-A2 | Process for producing 6-methyl-3-hepten-2-one, and process for producing phyton or isophytol | Kuraray Co., Ltd., Kurashiki Plant (JP) | 2001-08-08 | — | — | EP | disclosed |
| US-6232506-B1 | SUBJECTING ISOVALERALDEHYDE AND ACETONE TO CROSS ALDOL CONDENSATION CARRIED OUT WHILE CONTINUOUSLY ADDING TO ACETONE BOTH ISOVALERALDEHYDE AND AQUEOUS ALKALI CONTAINING ALKALINE SUBSTANCE TO GIVE 6-METHYL-3-HEPTEN-2-ONE | KURARAY CO., LYD. (JP) | 2001-05-15 | — | — | US | disclosed |
| US-6034279-A | REACTIG A TERTIARY ALLYL ALCOHOL WITH A ALKEYL ETHER I PRESECE OF ACID CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 2000-03-07 | — | — | US | disclosed |
| US-5955636-A | CROSS ALDOL CONDENSATION OF BRANCHED ALDEHYDE AND ACETONE; AQUEOUS ALKALI; HYDROGENATION CATALYST | KURARAY CO., LTD. (JP) | 1999-09-21 | — | — | US | disclosed |
| EP-0816321-A1 | Process for producing 6-methyl-3-hepten-2-one and 6-methyl-2-heptanone analogues, and process for producing phyton or isophytol | KURARAY CO., LTD. (JP) | 1998-01-07 | — | — | EP | disclosed |
| US-4179293-A | HYDROQUINONE COMPOUND AS AN ANTIFOGGING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1979-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130197276-A1 | ALKOXYLATES OF HYDROGENATED FARNESOLS AND USE THEREOF | ALKBH3, AKR7A2, FDPS | MEN1 1279/4885CYP3A4 260/4885ALOX15 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.